PSIX
Live / Applied — Response to non-final action entered (as of 16 Jan 2026)
What this means for you
Not registered yet, but its 18 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98809820
- Mark type
- Stylized text
- Filed
- 18 Oct 2024
- Attorney of record
- Stephen G. Anderson
Goods and services
- Class 005 — Pharmaceuticals: Mushroom extracts and compositions, other than essential oils, for pharmaceutical use.
Owner
- Empyrean Neuroscience, Inc., New York, NY, US
Prosecution history
- 16 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 16 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Jul 2025 — NON-FINAL ACTION E-MAILED
- 16 Jul 2025 — NON-FINAL ACTION WRITTEN
- 14 Jul 2025 — ASSIGNED TO EXAMINER
- 22 Apr 2025 — ASSIGNED TO EXAMINER
- 22 Apr 2025 — ASSIGNED TO EXAMINER
- 21 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Oct 2024 — NEW APPLICATION ENTERED